Russia receives renewed approval for COVID19 vaccine trials in India International News

 

Large-scale trials of the Sputnik V vaccine in India were first announced and then knocked back by Indian regulators, who said the scale of Phase I and II trials conducted in Russia earlier this year was too small, requesting that they be repeated.

Russia receives renewed approval for COVID19 vaccine trials in India
Bottles with Russia's Sputnik-V vaccine (Reuters))

 

Moscow: The Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday.

 

Large-scale trials of the Sputnik V vaccine in India were first announced and then knocked back by Indian regulators, who said the scale of Phase I and II trials conducted in Russia earlier this year was too small, requesting that they be repeated.

 

 

Following a new agreement, India will now carry out an adaptive phase II and III human clinical trial involving 1,500 participants, RDIF, which is marketing the vaccine abroad, said on Saturday. Under the deal, Dr. Reddy’s will conduct the clinical trials and, subject to approval, distribute the finished vaccine in India. RDIF will supply 100 million doses to Dr. Reddy’s.

 

 

Russia, the first country to grant regulatory approval for a novel coronavirus vaccine, is also conducting Phase III trials of Sputnik V in Belarus, Venezuela, and the United Arab Emirates. RDIF has reached agreements with Indian manufacturers to produce 300 million doses of the shot.

 

 

A Phase III trial involving 40,000 participants is currently underway in Moscow, with 16,000 people have already received the first dose of the two-shot vaccine.

 

 

Interim results are expected to be published in early November. Indian regulators have agreed to incorporate data, provided by Russia on a weekly basis, from the Moscow trial, a source close to the deal told Reuters.

 

 

Russia has also reached an agreement with the biotechnology department of India’s Science and Technology Ministry to use its laboratories as a base for the Indian clinical trial, the source said. (Reuters)

 



Posted Date :  17-10-20

Categories : International News

Tag Cloud: International News

Similar news

Israel and UAE companies sign MoU for energy collaboration

Israel: Israeli state-owned company Europe Asia Pipeline Company (EAPC) and MED-RED Land Bridge (MRLB), a joint venture between Petromal – an integrated oil and gas company based in Abu Dhabi – and other Israeli companies, have signed a binding MoU for energy collaboration.  
Posted Date :  21-10-20

Read more

EU opens anti dumping probe into Chinese steel wind towers

Brussels: The European Union has begun an anti-dumping investigation into imports from China of steel towers used for wind turbines, the EU official journal said on Wednesday.   The investigation follows a complaint by the European Wind Tower Association, which says the volumes and l
Posted Date :  21-10-20

Read more

KEPCO cancels foreign coal power investment

South Korea: South Korea’s majority state-owned utility KEPCO plans to cancel or convert to LNG two remaining overseas coal power projects in its pipeline, which includes the 630MW Thabametsi plant in South Africa and the 1,000MW Sual 2 project in the Philippines.   According t
Posted Date :  21-10-20

Read more

Oil prices steady but rising infections and oil supply weigh

Melbourne/Singapore: Oil prices were little changed on Tuesday, steadying after three days of declines due to worries that a resurgence of coronavirus cases globally is stifling a recovery in fuel demand, while growing output from Libya adds to plentiful supply. Brent crude futures were trading d
Posted Date :  20-10-20

Read more

UK and EU tell each other to move on trade

London/Brussels: Britain and the European Union said on Monday the door was still open to a deal, calling on each other to compromise to find a way to protect billions of dollars of trade between the neighbours. With just over two months before Britain ends a status-quo transition arran
Posted Date :  19-10-20

Read more

UK launches clinical trial of BCG vaccine against Covid-19

As part of a large-scale global trial, scientists in Britain have launched a study to test if the widely-used Bacillus Calmette-Guerin (BCG) vaccine could help protect people against Covid-19.   Developed almost a century ago, BCG vaccine was originally designed to fight tuberculosis (TB
Posted Date :  12-10-20

Read more

Meet the Americans standing by for possible election violence

A common fear is that the Nov. 3 contest between President Donald Trump and Democratic challenger Joe Biden remains undecided, leading to protests that could escalate into civil unrest, or even sectarian conflict. An illustration of those concerns came in Michigan on Thursday, with the announce
Posted Date :  09-10-20

Read more

Oman reintroduces nightly coronavirus curfew from 11 to 24 Oct

Dubai: Oman will re-introduce a night-time ban on movement and enforce the overnight closure of shops and public places between Oct. 11 and 24, to help contain the coronavirus, state media reported on Friday.   The restrictions will apply from 8 p.m. (2000 GMT) to 5 a.m. (0500 GMT)
Posted Date :  09-10-20

Read more

Greece’s Neo-Nazi leaders found guilty of running a crime gang

Greece: A Greek court on Wednesday found the leadership of Greece's neo-Nazi party convicted of running a criminal organization. This trail has been lasting for more than five years.    The judge gave the verdict on 68 defendants, a large number of people gathered outside the court
Posted Date :  07-10-20

Read more

Russia records over 11,000 COVID-19 cases in past 24-hour

Russia has registered 11,615 COVID 19 cases total to 1,237,504, the country’s corona virus response center said on Tuesday.   “In past 24 hours, Russia has confirmed 11,615 COVID 19 cases in 83 regions, of which 3,282 (28.3 percent) were detected actively, with people showing no clin
Posted Date :  06-10-20

Read more